Lupin receives final approval for Rosuvastatin Calcium Tablets
From USFDA
Lupin has received final USFDA approval for Rosuvastatin Calcium Tablets 5mg, 10mg, 20mg and 40mg to market a generic version of IPR Pharmaceuticals Inc's Crestor Tablets, indicated in adult patients with hypertriglyceridemia, primary dysbetalipoproteinemia and aduts patients with homozygous familial hypercholesterolemia.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content